Instant Report
FDF

Date: 01-Apr-2021

Chinese Firm To Make 60 Million Doses Of Russias Sputnik Vaccine

The Russian Direct Investment Fund (RDIF), which has financed the development of the vaccine, said it and Shenzhen Yuanxing Gene-tech Co. have agreed to cooperate on production of over 60 million doses of Sputnik in China. Russia has agreed a deal for more than 60 million doses of its Sputnik V vaccine to be produced in China from May, the jab's developer said on Monday.


The Russian Direct Investment Fund (RDIF), which has financed the development of the vaccine, said it and Shenzhen Yuanxing Gene-tech Co. "have agreed to cooperate on production of over 60 million doses" of Sputnik in China.

The RDIF, Russia's sovereign wealth fund that has backed the development of the vaccine, said that the amount of the two-dose vaccine would be enough to vaccinate some 30 million people, adding that production would begin in May.